Search research articles
Contact Us
Filters
Showing results (101-110 of 110) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 110 results.
British Journal of Cancer
|
January 8, 2009
A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer
Z Kote-Jarai, S Jugurnauth, S Mulholland, et al.
Andrology
|
July 17, 2019
Runs of homozygosity and testicular cancer risk
C Loveday, A Sud, K Litchfield, et al.
Journal of Medical Genetics
|
March 4, 2005
Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations
B Leegte, A H van der Hout, A M Deffenbaugh, et al.
British Journal of Cancer
|
October 4, 2006
Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer
I Griebsch, J Brown, C Boggis, et al.
Oral Oncology
|
May 10, 2005
Association between polymorphisms of the GPX1 gene and second primary tumours after index squamous cell cancer of the head and neck
S Jefferies, Z Kote-Jarai, D Goldgar, et al.
Prostate Cancer and Prostatic Diseases
|
January 5, 2018
Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases
L M FitzGerald, S Zhao, A Leonardson, et al.
British Journal of Cancer
|
August 27, 2009
The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers
O M Sinilnikova, A C Antoniou, J Simard, et al.
British Journal of Cancer
|
March 24, 2011
Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2
A Osorio, R L Milne, R Alonso, et al.
British Journal of Cancer
|
June 7, 2012
Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study
A Jakubowska, D Rozkrut, A Antoniou, et al.
British Journal of Cancer
|
November 19, 2009
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)
A Osorio, R L Milne, G Pita, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 110) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 110 results.
British Journal of Cancer
|
January 8, 2009
A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer
Z Kote-Jarai, S Jugurnauth, S Mulholland, et al.
Andrology
|
July 17, 2019
Runs of homozygosity and testicular cancer risk
C Loveday, A Sud, K Litchfield, et al.
Journal of Medical Genetics
|
March 4, 2005
Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations
B Leegte, A H van der Hout, A M Deffenbaugh, et al.
British Journal of Cancer
|
October 4, 2006
Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer
I Griebsch, J Brown, C Boggis, et al.
Oral Oncology
|
May 10, 2005
Association between polymorphisms of the GPX1 gene and second primary tumours after index squamous cell cancer of the head and neck
S Jefferies, Z Kote-Jarai, D Goldgar, et al.
Prostate Cancer and Prostatic Diseases
|
January 5, 2018
Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases
L M FitzGerald, S Zhao, A Leonardson, et al.
British Journal of Cancer
|
August 27, 2009
The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers
O M Sinilnikova, A C Antoniou, J Simard, et al.
British Journal of Cancer
|
March 24, 2011
Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2
A Osorio, R L Milne, R Alonso, et al.
British Journal of Cancer
|
June 7, 2012
Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study
A Jakubowska, D Rozkrut, A Antoniou, et al.
British Journal of Cancer
|
November 19, 2009
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)
A Osorio, R L Milne, G Pita, et al.
Page
of 11